Tower Research Capital LLC (Trc) Spero Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 269 shares of SPRO stock, worth $317. This represents 0.0% of its overall portfolio holdings.

Number of Shares

269

Previous 276 2.54%

Holding current value

$317

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.19 - $1.5 $8 - $10	-7 Reduced 2.54%	269 $0
Q2 2024 Aug 13, 2024	BUY	$1.27 - $1.8 $76 - $108	60 Added 27.78%	276 $0
Q1 2024 May 15, 2024	BUY	$1.35 - $1.79 $290 - $384	215 Added 21500.0%	216 $0
Q4 2023 Feb 13, 2024	SELL	$1.0 - $1.47 $571 - $839	-571 Reduced 99.83%	1 $0
Q3 2023 Nov 14, 2023	BUY	$1.2 - $1.63 $644 - $875	537 Added 1534.29%	572 $0
Q2 2023 Aug 14, 2023	SELL	$1.42 - $1.95 $718 - $986	-506 Reduced 93.53%	35 $0
Q1 2023 May 09, 2023	SELL	$1.35 - $2.0 $44,041 - $65,246	-32,623 Reduced 98.37%	541 $1,000
Q4 2022 Feb 10, 2023	BUY	$1.55 - $2.12 $23,133 - $31,641	14,925 Added 81.83%	33,164 $57,000
Q3 2022 Nov 10, 2022	SELL	$0.68 - $2.2 $4,649 - $15,043	-6,838 Reduced 27.27%	18,239 $37,000
Q2 2022 Aug 15, 2022	BUY	$0.74 - $7.44 $9,363 - $94,145	12,654 Added 101.86%	25,077 $19,000
Q1 2022 May 12, 2022	BUY	$7.87 - $15.15 $28,764 - $55,373	3,655 Added 41.69%	12,423 $108,000
Q4 2021 Feb 14, 2022	BUY	$13.09 - $18.77 $101,591 - $145,673	7,761 Added 770.71%	8,768 $141,000
Q3 2021 Nov 15, 2021	SELL	$13.03 - $19.51 $96,122 - $143,925	-7,377 Reduced 87.99%	1,007 $19,000
Q2 2021 Aug 16, 2021	BUY	$12.22 - $15.79 $64,008 - $82,708	5,238 Added 166.5%	8,384 $117,000
Q1 2021 May 17, 2021	BUY	$13.23 - $21.48 $26,274 - $42,659	1,986 Added 171.21%	3,146 $46,000
Q4 2020 Feb 16, 2021	SELL	$11.65 - $22.07 $170,369 - $322,751	-14,624 Reduced 92.65%	1,160 $22,000
Q3 2020 Nov 16, 2020	BUY	$8.96 - $14.12 $116,865 - $184,167	13,043 Added 475.85%	15,784 $176,000
Q2 2020 Aug 13, 2020	BUY	$7.27 - $14.18 $19,927 - $38,867	2,741 New	2,741 $37,000
Q4 2019 Feb 07, 2020	SELL	$9.46 - $12.16 $2,109 - $2,711	-223 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$9.01 - $12.55 $4,459 - $6,212	-495 Reduced 68.94%	223 $2,000
Q2 2019 Aug 13, 2019	BUY	$10.25 - $14.36 $7,359 - $10,310	718 New	718 $8,000
Q1 2019 May 14, 2019	SELL	$6.26 - $13.31 $7,011 - $14,907	-1,120 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.69 - $11.28 $6,156 - $12,204	1,082 Added 2847.37%	1,120 $7,000
Q3 2018 Nov 13, 2018	SELL	$9.69 - $17.79 $959 - $1,761	-99 Reduced 72.26%	38 $0
Q2 2018 Aug 15, 2018	BUY	$10.41 - $17.85 $1,426 - $2,445	137 New	137 $2,000
Q1 2018 May 15, 2018	SELL	$9.96 - $14.61 $20,806 - $30,520	-2,089 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$10.43 - $14.75 $21,788 - $30,812	2,089	2,089 $24,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $41.4M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Spero Therapeutics, Inc. Transaction History